Shares of the company are trading at $41.85 a great deal higher than the 50 day moving average of $34.09 and quite a bit higher than the 200 day moving average of $30.94. The 50 day moving average went up $7.76 or +22.78% whereas the 200 day average was up by +35.24%. Trading volume for Exactech, Inc. was 308K on Tuesday. Overall, volume was up 7.14% over the stocks normal daily volume.
Investors are more bullish on Exactech, Inc. if you pay attention to the change in short interest. The stock saw a fall in short interest of -10.96% as of the latest report on October 13, 2017. Short interest fell from 116,038 to 103,318 over that period. With short interest at 103,318 and short average daily volume at 24,818, the short-interest ratio is 4.0 and the percentage of shorted shares is 0.01% as of October 13.
The following firms have recently changed their position in EXAC. Bank Of Montreal /can/ downsized its investment by shedding 386 shares a decrease of 17.1%. Bank Of Montreal /can/ currently owns 1,868 shares valued at $62,000. The total value of its holdings decreased 7.5%. Thomson Horstmann & Bryant Inc trimmed its ownership by selling 18,247 shares a decrease of 6.7% from 06/30/2017 to 09/30/2017. Thomson Horstmann & Bryant Inc now holds 255,815 shares with a value of $8,429,000. The value of the position overall is up by 3.2%.
First Trust Advisors Lp divested its stake by selling 55 shares a decrease of 0.7% as of 09/30/2017. First Trust Advisors Lp now controls 8,388 shares worth $276,000. The value of the position overall is up by 9.5%. Kirr Marbach & Co LLC /in/ added to its position by buying 125 shares an increase of 0.7% in the quarter. Kirr Marbach & Co LLC /in/ claims 16,985 shares worth $560,000. The value of the position overall is up by 11.6%.
The company’s P/E ratio is 804.81 and market cap is 600.46M. In the latest earnings report the EPS was $0.05 and is projected to be $1.30 for the current year with 14,348,000 shares outstanding. Next quarter’s EPS is forecasted at $0.35 with next year’s EPS anticipated to be $1.41.
Exactech, Inc. (Exactech), launched on November 13, 1985, develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. The Business’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures..